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A B S T R A C T
Determination of anti-citrullinated peptides (anti-CCP) specificity as a predictor of joint erosive changes, correlation
between their serum level and radiological damages as well as disease activity score (DAS28). A trial has been conducted
on a 211 patient sample fulfilling ACR criteria for rheumatoid arthritis (RA). There was assigned anti-CCP serum level,
disease activity score by the formula for DAS28(3)-CRP and assessed radiological changes degree after Steinbrocker
score. In 132 patient (62,559%) the serum anti-CCP concentration was positive for RA. Specificity of the test was 100%
and sensitivity 65% (Z=0,731, p=0,465). There is a medium intensity correlation between variables representing anti-
-CCP and Steinbrocker score. Pearson’s coefficient was 0,479 and Spearman’s rank correlation coefficient was 0,614, i.e.
statistically significant (p=0,000). There is no statistically significant correlation between variables representing anti-
-CCP and DAS28(3)-CRP. Anti-CCP are good RA predictor and their concentration correlate with radiological damages
degree.
Key words: anti-citrullinated antibodies, rheumatoid arthritis, disease activity score, radiological damages
Introduction
Rheumatoid arthritis (RA) is the most common in-
flammatory joint disease, affecting nearly 1% of the adult
population worldwide. It is characterized by multiple de-
formities and is associated with considerable morbiditiy
and mortality1. Although the precise etiology of RA re-
mains unknown, there is a strong evidence for autoim-
munity. Several auto-antibodies are associated with the
disease. Besides the rheumatoid factor (RF), another
group of auto-antibodies has recently been detected in
the serum of patients with RA: the anti-cyclic citrullina-
ted peptide antibodies (anti-CCP)2. The disease activity
score (DAS) is a continuous measure of RA that is becom-
ing increasingly utilized in clinical research and practice.
DAS commonly uses a 28-count for tender and swollen
joints (DAS28) and can be calculated as originally devel-
oped using ESR (DAS28-ESR) or with a more recent for-
mula that uses CRP (DAS-CRP)3. Several observations
have indicated that an anti-CCP positive in early RA pa-
tients may develop a more erosive disease than those
without an anti-CCP, and it has been shown that anti-
-CCP can be an independent predictor for radiological
damage and progression4–6. There is a question whether
serum anti-CCP is able to be an objectivity test on joint
changes in RA patients and if its concentration may be
an indicator of inflammatory activity as DAS28(3)-CRP.
Materials and Methods
The trial has been conducted on a 211- patient sample
fulfilling ACR criteria for RA and 243 control patients
with other autoimmune diseases7. Anti-CCP serum level
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was determined by an ELISA test of the firm Euroim-
mune on the MiniBos apparatus (referent range of anti-
-CCP  5(25) RU/mL negative, antiCCP  5(25) RU/mL
positive). The Waaler Rose (WR) was determinated with
the hemaglutination technique of the firm Chronolab,
Switzerland. The WR test reagent sensivity hay been ad-
justed to detect a minimum of a 6 IU/mL of rheumatoid
factors according with the WHO International Standard
without previous sample dilution.
CRP was determined by the immuno-turbidimeter
test of the firm Olympus on a multi-channel analyzer
Olympus AU 640 (referent range 0–5 mg/L).
DAS28-CRP was determined by the formula:
DAS28-(3)CRP = 0.56  sqrt(TJC28) + 0.28 
 sqrt(SJC28) + 0.36  ln(CRP+1)  1.10 + 1.15.
CRP is a more direct measure of inflammation com-
pared to ESR and is more sensitive to short term changes.8
The degree of joint radiological changes has been esti-
mated by the Steinbrocker score. Data input and manip-
ulation was done in a computer table calculator Micro-
soft Excel 2003 whereas software packages SPSS 13.0 for
Windows and Statistica 6.0 were used in the statistical
analysis.
Results
Out of 211 patients included in our study who fulfilled
all the ACR criteria for RA 23.69% of patients were male
and 76.30% were female. The average age was 52.963±
12.45, with a median length of illness of 4 years. In all the
patients diagnosed with RA, DMARD therapy was in-
cluded.
In 132 patients (62.559%) the serum level of anti-CCP
was higher than 5 RU/mL and in 79 patients (37.441%)
was lower than 5 RU/mL. The specificity of the test was
100% as there was no positive result in any case of the
control group. A positive Waaler Rose test was proven in
95 anti-CCP positive patients. According to the degree of
radiological changes on the joints we had 50 patients in
the first group or 37.878%, 49 patients in the second
group or 37.712%, 31 patients in the third group or
23.484% and 2 patients in the forth group or 1.515%.
The testing showed that it is possible to accept a se-
lected hypothesis on the proportion of patients in the ba-
sic group out of which a concentration of anti-CCP in the
serum -a predictor for rheumatoid arthritis (RA) is 0.65
(Z=0.731, p=0.465).
A simple linear regression model where anti-CCP is
defined as an independent variable and dependent Stein-
brocker score, runs like this. (Figure 1)
A constant member in a regression equation shows a
possible expected Steinbrocker score value in RA pa-
tients if anti-CCP in serum is 0. Based upon the com-
puted regression coefficient it can be concluded that a pa-
tient serum anti-CCP increase by 1 resulted in the mean
Steinbrocker score of 0.007.
Pearson’s correlation coefficient values are 0.479 in
this case. Thus, there is a positive mean-intensive corre-
lation between variables representing anti-CCP and
Steinbrocker score. The hypothesis where the computed
correlation coefficient is statistically significant is ac-
cepted (p=0.000). The determination coefficient shows
that only 22.97% of total deviations have been explained
by the applied linear regression model. The computed
equation of linear regression cannot be considered as a
representative one. Testing of the hypothesis on variable
significance representing anti-CCP and conducted by the
F-test shows that it can be a possible hypothesis on the
variable significance in the applied model (F=38.766,
p=0.000). The hypothesis on the computed parameter
excess was rejected after t-test had been performed (t=
6.226, p=0.000). The standard parameter assessment er-
ror alongside variable designating anti-CCP is 0.001.
With 95% of reliability anti-CCP increase by 1 is expected
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Fig 1. Diagram of anti-citrullinated antibodies value and Stein-

























Fig. 2 Box plot of anti-citrullinated antibodies and Steinbrocker
score
to result in the mean Steinbrock score increase by more
than 0.005 and less than 0.01. According to Spearman’s
rank correlation coefficient of 0.614, there is a positive
mean-intensive correlation between the observed vari-
ables. The computed Spearman’s rank correlation coeffi-
cient is statistically significant (p=0.000). With 95% reli-
ability the mean anti-CCP result is expected to be higher
than 20.021 and lower than 47.627 in persons having
Steinbrocker 1 (Table 1 and Figure 2). Since the hypothe-
sis on variance homogeneity by Leveneo’s test had been
accepted, the one-factor variance analysis was applied in
testing the hypothesis on arithmetic means equality. It
appeared to be a feasible hypothesis on the presence of
statistically significant differences in the mean values of
CCP three patient groups designed by the Steinbrocker
score (p=0.000, Table 2).
Of 133 anti-CCP positive patients DAS28(3)-CRP was
calculated in 78 (58.64%). There is a slight positive corre-
lation between variables representing anti-CCP and
DAS28(3)-CRP. Pearson’s correlation coefficient was
0.0475, and the determination coefficient amounted to
0.206%. The hypothesis whereby the computed correla-
tion coefficient is significant (p=0.693) has been re-
jected. Testing the hypothesis on the significance of the
variable representing anti-CCP conducted by the test
shows that the hypothesis on the significance of this ap-
plied model variable cannot be accepted (F=0.125, p=
0.693). The hypothesis on the computed parameter ex-
cess was not rejected after t-test had been performed
(t=0.396, p=0.693). By Spearman’s rank, the correlation
coefficient of the value 0,042 showed a slight positive cor-
relation between the observed variables. The computed
rank correlation coefficient (is not statistically signifi-
cant (p=0.717).
Discussion
In our study we wanted to show the patients who ful-
filled the currently valid ACR criteria for RA. By deter-
mining a degree of radiological changes on the hand
joints, as RA objectivity tests, as well as by dividing the
patients in 4 groups by Stainbrocker score, which might
be an obsolete but still a frequently used degree method
in everyday medical practice, we determined the serum
level of anti-CCP and put them in an interactive correla-
tion.
The results of our study show that there is a correla-
tion between anti-CCP serum level and joint changes.
Their level, with 95% of reliability, indicates a degree of
radiological lesions. The first degree of Steinbrocker sco-
re described radiological changes that were characterized
by the largest number of extremely high anti-CCP re-
sults. This perhaps is not consistent with radiological le-
sions degree. However, this is where anti-CCP show their
significance since these patients are shown to have the
highest risk of erosive changes development. The deter-
mination of anti-CCP and x-rays of hand joints, as ero-
sive lesions objective tests, are of special importance for
setting RA diagnosis, and making decisions on the intro-
duction of DMARD medicines as well as patient monitor-
ing. Furthermore, although Steinbrocker score recog-
nizes only 4 degrees of radiological changes, as we had in
our group of patients only 2 such patients, we could not
bring any conclusions. Nevertheless, their serum level of
anti-CCP was lower than expected, probably due to se-
vere deterioration of the cartilage with the bone damage
and joint deformity. Anti-CCP is a good serological RA
marker. Due to a high specificity being 100% in our study,
it is valuable to differentiate RA from other arthritis
forms that can also be erosive. However, 18 anti-CCP
positive patients had clinical and serous inclinations of
autoimmune or any other disease. (SEL, ReA, PsA), but
as they also fulfilled the ACR criteria for RA, it is possible
that there was a syndrome of aliasing. In these situations
it would be advisable to make HLA typification to deter-
mine the final diagnosis. The introduction of anti-CCP
positive into RA diagnosis criteria would certainly make
its diagnosis much easier9. However, in spite of anti-CCP
great prognostic importance for the prediction of joint
erosive changes, there is a question whether there is a
correlation between serum anti-CCP level and joint-
change degrees as well as the possibility of using their
level as an indicator of inflammatory activity instead of
DAS28. Great controversies and debates are raised upon
this issue. In the estimation of the disease activity, we
used DAS28(3)-CRP because CRP can be used as an al-
ternative for ESR in determination of inflammation.
CRP is a more direct measure of inflammation than ESR.
CRP production is associated with radiological progres-
sion in RA10 and is considered at least as valid as ESR to
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TABLE 1
RESULTS OF THE INTERVAL VALUE ASSESSMENT OF THE
VARIABLE DEFINED AS ANTICITRULLINATED ANTIBODIES











1 33.824 6.869 20.021 47.627
2 67.902 4.493 58.872 76.932
3 103.901 11.489 80.404 127.398
TABLE 2
RESULTS OF THE LEVENS TEST HOMOGENEITY OF
VARIANCES AND HYPOTHESIS TEST ON EQUALITY OF
ANTICITRULLIINATED ANTIBODIES MEANS OF THREE







0.133 0.876 21.315 0.000
measure RA disease activity11,12. Another advantage of
the determination of CRP is that the waiting time for the
laboratory result is shorter and that in case of multi-
center studies a central laboratory can be used. By putting
in a correlation the patients who were anti-CCP positive
and the patients had their DAS28(3)-CRP determined,
we could not prove any statistic connection. The serum
level itself will, therefore, not determine the degree of
the very activity of the illness nor the number of the
joints which would be affected by the disease. A small
number of patients have been found to change their
anti-CCP status in the 5 year period.4,6,13–15 The latest pa-
pers, also approved by our study, show that changes in
antibody concentration do not reflect disease activity de-
gree and cannot be used for disease activity assessment.
The aforementioned can depend on the treatment fa-
shion1. Alessandri et.al. showed that anti-CCP concen-
tration measures may be useful in effect assessment of
treating RA patients with anti-TNF preparations17. Most
research has shown that progression of radiological le-
sions correlates with initial anti-CCP level15,18,19.
In summary, anti-CCP characterized by specificity
and early positive is shown to be an excellent RA diag-
nostic marker. Its serum level correlates with a radiologi-
cal change degree. Thus, based upon 95% reliability, it
can be used for erosive lesions assessment instead of the
objectivity test. Still, their serum level can not be a sub-
stitute parameter in assessing disease activity degree in-
stead of DAS28-(3)-CRP. Therefore, previously defined
parameters should be determined for the aforementio-
ned purpose.
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ANTICITRULINKSA PROTUTIJELA I STUPANJ RADIOLO[KIH PROMJENA TE NJIHIVA
KORELACIJA SA STUPNJEM AKTIVNOSTI BOLESTI (DAS28)
S A @ E T A K
Cilj rada bio je odrediti specifi~nost anticitrulinskih protutijela (anti-CCP) kao prediktora erozivnih promjena na
zglobovima, korelaciju njihove serumske razine i radiolo{kih promjena kao i stupnjem aktivnosti bolesti (DAS28). Stu-
dija je obuhvatila 211 pacijenata koji su ispunjavali ACR kriterije za reumatioidni artritis (RA). Odre|ena im je razina
anti-CCP u serumu, stupanj aktivnosti bolesti te stupanj radiolo{kih promjena po Steinbrocker scoru. U 132 pacijenta
(62.559%) serumska razina anti-CCP bila je indikativna za RA. Specifi~nost testa bila je 100%, a osjetljivost 65% (Z= 0.731,
p= 0.465). Postoji korelacija srednje jakosti izme|u varijabli anti-CCP i Stinebrocker score. Paersonov koeficijent je
0.479 a Spearmanov koeficijent korelacije 0.614; oboje statisti~ki zna~ajni (p=0.000). Nema statisti~ke zna~ajnosti iz-
me|u varijabli anti-CCP i DAS28(3)-CRP. Anti-CCP je dobar prediktor za RA i njihova serumska razina korelira s
radiolo{kim promjenama na zglobovima.
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